Are You Looking for a Top Momentum Pick? Why Supernus Pharmaceuticals (SUPN) is a Great Choice

Core Viewpoint - Supernus Pharmaceuticals (SUPN) is identified as a strong momentum stock with a Zacks Rank of 1 (Strong Buy) and a Momentum Style Score of B, indicating potential for significant near-term gains [4][12]. Company Performance - SUPN shares have increased by 1.28% over the past week, outperforming the Zacks Medical - Generic Drugs industry, which rose by 0.97% during the same period [6]. - Over the last month, SUPN's stock price has risen by 4.5%, compared to the industry's 1.4% [6]. - In the last quarter, SUPN shares have surged by 46.87%, and over the past year, they have gained 57.31%, significantly outperforming the S&P 500, which increased by 9.31% and 17.01% respectively [7]. Trading Volume - The average 20-day trading volume for SUPN is 645,479 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the past two months, two earnings estimates for SUPN have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $1.50 to $2.18 [10]. - For the next fiscal year, two estimates have also moved upwards with no downward revisions [10].